TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks withMIT professor DAVID MINDELL about “Our Robots, Ourselves: Robotics and the Myths of Autonomy.” He’s out to dispel the “persistent misconceptions about robots.”Then on BioTech Nation, what biotech is doing for rare diseases in boys – progress in hemophilia and Duchene Muscular Dystrophy?

On this week’s Tech Nation, Moira speaks with A BioTech Nation Special!DR CHARLOTTE JACOBS, the author of “Jonas Salk: A Life”. They re-visit 1950’s America under the threat of Polio – what did science know and what had it gotten wrong?Then on BioTech Nation, JAY LICHTER, Co-founder of Otonomy, tells us about his diagnosis of Menieres disease, and how, as a venture capitalist, he decided to start a company to find better treatment options on the spot.

On this week’s Tech Nation, Moira speaks with A BioTech Nation Special!DANIEL LEVITIN, Dean, Arts & Humanities at the Minerva Schools at KGI talks about his latest neuroscience research on empathy and pain.And on BioTech Nation, on BioIssue Issue of the Week with DAVID EWING DUNCAN, a potential new and different approach to treating Alzheimer’s and other forms of dementia.

On this week’s Tech Nation, Moira speaks with A BioTech Nation Special!DR. MARSHALL SUMMAR from Children’s National Medical Center and JIM POWERS, CEO of Hemoshear Therapeutics. They talk about their breakthrough collaboration helping a young girl and her rare disease.Then Darren Cunningham, the CEO of Inflection Biosciences in Dublin, Ireland. This start-up did things differently – they didn’t start with new science; they started with a checklist.

On this week’s Tech Nation, Moira speaks with New York Times journalist JOHN MARKOFF about “Machines of Loving Grace.”Then on BioTech Nation, STAN ERCK, the President & CEO of NovaVax joins us to talk about their “RSV” vaccine for the elderly, as well as for pregnant mothers to reach their newborns.

On this week’s Tech Nation, Moira speaks with BOB CHAPMAN, Chairman & CEO of a long-time company of many companies - Barry-Wehmiller. They’ve acquired 75 companies in trouble while preserving employee trust.Then on BioTech Nation, DR. TONY SHUH, the CEO of Trovagene, talks about precision cancer monitoring, and DR. YUVAL COHEN, the CEO of Corbus Pharmaceuticals tells us about a new approach for cystic fibrosis and their efforts surrounding auto-immune diseases.

On this week’s Tech Nation, Moira speaks with a group of distinguished professors from Stanford University, UC Berkeley, UCSF and the University of San Francisco. They explain each of the 2015 Nobel Prizes, and why each prize was so deserving.Convener, Dr. Ludwig Chincarini, University of San FranciscoPEACE PRIZE, Dr. Rebecca Gordon, University of San FranciscoLITERATURE. Dr. Susanna Elm, University of California BerkeleyPHYSIOLOGY OR MEDICINE Dr. Darvin Scott Smith, Kaiser PermanenteECONOMICS Dr. Michael Boskin, Stanford UniversityCHEMISTRY Dr. Jim Cleaver UCSF - University of California San FranciscoPHYSICS Dr Yasunori Nomura, University of California Berkeley

On this week’s Tech Nation, Moira speaks with DAVID PETERSON, a creator of alien languages, including Dothraki for HBO’s Game of Thrones. He’s here with The Art of Language Invention: From Horse-Lords to Dark Elves, the Words Behind World-Building.Then on BioTech Nation, Merck’s DR ROY BAYNES takes us through their wide ranging cancer program based on their therapeutic: Keytruda, and on BioIssue of the Week with David Ewing Duncan, IT meets biotech.

On this week’s Tech Nation, it’s the second of a two-part series on Digital Health. On this show, Moira speaks with DR. RAJAIE BATNIJI, the Co-Founder & Chief Health Officer of Collective Health. It all started with a nightmare in filing health claims.Then on BioTech Nation, Rif Pamukcu, the CEO of RxMP Therapeutics. It’s about the technology of stopping blood loss.

On this week’s Tech Nation, it’s the first of a two-part series on Digital Health. On this show, Moira speaks withRAY BRADFORD, the Founder of Spruce Health, with their smartphone app which enabling you to be treated by a dermatologist. It’s working in 15 states and expanding rapidly.Then on BioTech Nation, SPIRO ROMBOTIS, the President & CEO of Cyclacel Pharmaceuticals, talks about their approach to treating Leukemia in the aging population, and PARIS PANAYIOTOPOULOS, President of EMD Serono, talks about moving beyond specialty therapeutics into developing new cancer treatments.